Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Isolated cerebral mucormycosis associated with intravenous drug use.

PMID: 33067115
Journal: JOURNAL DE MYCOLOGIE MEDICALE
Year: 2020
Reference: J Mycol Med. 2020 Dec;30(4):101046. doi: 10.1016/j.mycmed.2020.101046. Epub 2020 Oct 6.
Impact factor: 1.56
Publication type: Letter or abstract
Authors: Dura-Miralles, X, Escola-Verge, L, Moreno, D, Martinez-Ricarte, F, Lung, M, Fernandez-Hidalgo, N, Auger, C, Martin-Gomez, M-T et al.
DOI: 10.1016/j.mycmed.2020.101046

Isolated cerebral mucormycosis associated with intravenous drug use.

PMID: 33067115
Journal: JOURNAL DE MYCOLOGIE MEDICALE
Year: 2020
Reference: J Mycol Med. 2020 Dec;30(4):101046. doi: 10.1016/j.mycmed.2020.101046. Epub 2020 Oct 6.
Impact factor:
Publication type: Letter or abstract
Authors: Auger, C; Dura-Miralles, X; Escola-Verge, L; Fernandez-Hidalgo, N; Lung, M; Martin-Gomez, M-T; Martinez-Ricarte, F; Moreno, D et al.
DOI: 10.1016/j.mycmed.2020.101046

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

PMID: 31943195
Journal: HEADACHE
Year: 2020
Reference: Headache. 2020 Mar;60(3):576-588. doi: 10.1111/head.13731. Epub 2020 Jan 13.
Impact factor: 4.041
Publication type: Paper in international publication
Authors: Kudrow, David, Krege, John H, Hundemer, Hans P, Berg, Paul H, Khanna, Rashna, Ossipov, Michael H, Pozo-Rosich, Patricia et al.
DOI: 10.1111/head.13731

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

PMID: 31943195
Journal: HEADACHE
Year: 2020
Reference: Headache. 2020 Mar;60(3):576-588. doi: 10.1111/head.13731. Epub 2020 Jan 13.
Impact factor:
Publication type: Paper in international publication
Authors: Berg, Paul H; Hundemer, Hans P; Khanna, Rashna; Krege, John H; Kudrow, David; Ossipov, Michael H; Pozo-Rosich, Patricia et al.
DOI: 10.1111/head.13731

Italian consensus on treatment of spasticity in multiple sclerosis.

PMID: 31652369
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2020
Reference: Eur J Neurol. 2020 Mar;27(3):445-453. doi: 10.1111/ene.14110. Epub 2019 Dec 3.
Impact factor: 4.516
Publication type: Paper in international publication
Authors: Comi, G, Solari, A, Leocani, L, Centonze, D, Otero-Romero, S, Amadeo, Roberta, Amato, Maria Pia, Bertolotto, Antonio, Boffa, Laura, Brichetto, Giampaolo et al.
DOI: 10.1111/ene.14110

Italian consensus on treatment of spasticity in multiple sclerosis.

PMID: 31652369
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2020
Reference: Eur J Neurol. 2020 Mar;27(3):445-453. doi: 10.1111/ene.14110. Epub 2019 Dec 3.
Impact factor:
Publication type: Paper in international publication
Authors: Amadeo, Roberta; Amato, Maria Pia; Bertolotto, Antonio; Boffa, Laura; Brichetto, Giampaolo; Centonze, D; Comi, G; Comola, Mauro; Ghezzi, Angelo; Leocani, L et al.
DOI: 10.1111/ene.14110

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

PMID: 32848136
Journal: Nature Communications
Year: 2020
Reference: Nat Commun. 2020 Aug 26;11(1):4261. doi: 10.1038/s41467-020-18081-9.
Impact factor: 12.121
Publication type: Paper in international publication
Authors: Fuentes, Pedro, Sese, Marta, Guijarro, Pedro J, Emperador, Marta, Sanchez-Redondo, Sara, Peinado, Hector, Hummer, Stefan, Ramon Y Cajal, Santiago et al.
DOI: 10.1038/s41467-020-18081-9

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

PMID: 32848136
Journal: Nature Communications
Year: 2020
Reference: Nat Commun. 2020 Aug 26;11(1):4261. doi: 10.1038/s41467-020-18081-9.
Impact factor:
Publication type: Paper in international publication
Authors: Emperador, Marta; Fuentes, Pedro; Guijarro, Pedro J; Hummer, Stefan; Peinado, Hector; Ramon Y Cajal, Santiago; Sanchez-Redondo, Sara; Sese, Marta et al.
DOI: 10.1038/s41467-020-18081-9

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

PMID: 32424932
Journal: ALLERGY
Year: 2020
Reference: Allergy. 2020 Dec;75(12):3171-3183. doi: 10.1111/all.14406. Epub 2020 Jul 3.
Impact factor: 8.706
Publication type: Paper in international publication
Authors: Salgado, Francisco Javier, Nieto-Fontarigo, Juan Jose, Gonzalez-Barcala, Francisco Javier, Andrade-Bulos, Luis Juan, San-Jose, Maria Esther, Cruz, Maria Jesus, Valdes-Cuadrado, Luis, Crujeiras, Rosa Maria, Arias, Pilar et al.
DOI: 10.1111/all.14406

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

PMID: 32424932
Journal: ALLERGY
Year: 2020
Reference: Allergy. 2020 Dec;75(12):3171-3183. doi: 10.1111/all.14406. Epub 2020 Jul 3.
Impact factor:
Publication type: Paper in international publication
Authors: Andrade-Bulos, Luis Juan; Arias, Pilar; Crujeiras, Rosa Maria; Cruz, Maria Jesus; Gonzalez-Barcala, Francisco Javier; Nieto-Fontarigo, Juan Jose; Salgado, Francisco Javier; San-Jose, Maria Esther; Valdes-Cuadrado, Luis et al.
DOI: 10.1111/all.14406

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

PMID: 32416072
Journal: LANCET ONCOLOGY
Year: 2020
Reference: Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13.
Impact factor: 33.752
Publication type: Paper in international publication
Authors: Wu, Bin, Chamberlain, Christina X, Jiang, Liewen, Gliser, Camelia, Pandya, Shuchi S, Valle, Juan W, Zhu, Andrew X, Fan, Bin, El-Khoueiry, Anthony B, Shroff, Rachna T et al.
DOI: 10.1016/S1470-2045(20)30157-1

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

PMID: 32416072
Journal: LANCET ONCOLOGY
Year: 2020
Reference: Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13.
Impact factor:
Publication type: Paper in international publication
Authors: Abou-Alfa, Ghassan K; Adeva, Jorge; Borad, Mitesh J; Bridgewater, John; Catenacci, Daniel V; Chamberlain, Christina X; Cleary, James M; El-Khoueiry, Anthony B; Fan, Bin; Gliser, Camelia et al.
DOI: 10.1016/S1470-2045(20)30157-1

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

PMID: 32343960
Journal: GASTROENTEROLOGY
Year: 2020
Reference: Gastroenterology. 2020 Aug;159(2):521-533.e9. doi: 10.1053/j.gastro.2020.04.036. Epub 2020 Apr 25.
Impact factor: 17.373
Publication type: Paper in international publication
Authors: Zoulim, Fabien, Lenz, Oliver, Vandenbossche, Joris J, Talloen, Willem, Verbinnen, Thierry, Moscalu, Iurie, Bourgeois, Stefan, Buti, Maria, Crespo, Javier, Pascasio, Juan Manuel et al.
DOI: 10.1053/j.gastro.2020.04.036

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

PMID: 32343960
Journal: GASTROENTEROLOGY
Year: 2020
Reference: Gastroenterology. 2020 Aug;159(2):521-533.e9. doi: 10.1053/j.gastro.2020.04.036. Epub 2020 Apr 25.
Impact factor:
Publication type: Paper in international publication
Authors: Bourgeois, Stefan; Buti, Maria; Crespo, Javier; Fry, John; Lenz, Oliver; Moscalu, Iurie; Pascasio, Juan Manuel; Sarrazin, Christoph; Shukla, Umesh; Streinu-Cercel, Adrian et al.
DOI: 10.1053/j.gastro.2020.04.036

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

PMID: 32272210
Journal: ANNALS OF ONCOLOGY
Year: 2020
Reference: Ann Oncol. 2020 Jul;31(7):861-872. doi: 10.1016/j.annonc.2020.03.299. Epub 2020 Apr 6.
Impact factor: 18.274
Publication type: Paper in international publication
Authors: Yoshino, T, Pentheroudakis, G, Mishima, S, Overman, M J, Yeh, K-H, Baba, E, Naito, Y, Calvo, F, Saxena, A, Chen, L-T et al.
DOI: 10.1016/j.annonc.2020.03.299

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

PMID: 32272210
Journal: ANNALS OF ONCOLOGY
Year: 2020
Reference: Ann Oncol. 2020 Jul;31(7):861-872. doi: 10.1016/j.annonc.2020.03.299. Epub 2020 Apr 6.
Impact factor:
Publication type: Paper in international publication
Authors: Baba, E; Burris, H; Calvo, F; Cervantes, A; Chen, L-T; Douillard, J-Y; Kitagawa, Y; Kodera, Y; Mishima, S; Naito, Y et al.
DOI: 10.1016/j.annonc.2020.03.299

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

PMID: 31066634
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Jul;26(8):912-923. doi: 10.1177/1352458519845844. Epub 2019 May 8.
Impact factor: 5.412
Publication type: Paper in international publication
Authors: Hegen, H, Leurs, C E, Twaalfhoven, Ham, Lissenberg-Witte, B I, van Pesch, V, Dujmovic, I, Drulovic, J, Castellazzi, M, Bellini, T, Pugliatti, M et al.
DOI: 10.1177/1352458519845844

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

PMID: 31066634
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Jul;26(8):912-923. doi: 10.1177/1352458519845844. Epub 2019 May 8.
Impact factor:
Publication type: Paper in international publication
Authors: Altintas, A; Alvarez-Cermeno, J C; Alvarez-Lafuente, R; Bellini, T; Bridel, C; Castellazzi, M; Comabella, M; Deisenhammer, F; Drulovic, J; Dujmovic, I et al.
DOI: 10.1177/1352458519845844

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

PMID: 32552382
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Sep;26(10):1153-1156. doi: 10.1177/1352458520931785. Epub 2020 Jun 19.
Impact factor: 5.412
Publication type: Editorail in international publication
Authors: Sastre-Garriga, Jaume, Tintore, Mar, Montalban, Xavier et al.
DOI: 10.1177/1352458520931785

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

PMID: 32552382
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Sep;26(10):1153-1156. doi: 10.1177/1352458520931785. Epub 2020 Jun 19.
Impact factor:
Publication type: Editorail in international publication
Authors: Montalban, Xavier; Sastre-Garriga, Jaume; Tintore, Mar et al.
DOI: 10.1177/1352458520931785

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

PMID: 32669323
Journal: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Year: 2020
Reference: J Am Soc Nephrol. 2020 Sep;31(9):1941-1943. doi: 10.1681/ASN.2020050667. Epub 2020 Jul 15.
Impact factor: 9.274
Publication type: Letter whit IF
Authors: Wysocki, Jan, Lores, Enrique, Ye, Minghao, Soler, Maria Jose, Batlle, Daniel et al.
DOI: 10.1681/ASN.2020050667

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

PMID: 32669323
Journal: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Year: 2020
Reference: J Am Soc Nephrol. 2020 Sep;31(9):1941-1943. doi: 10.1681/ASN.2020050667. Epub 2020 Jul 15.
Impact factor:
Publication type: Letter whit IF
Authors: Batlle, Daniel; Lores, Enrique; Soler, Maria Jose; Wysocki, Jan; Ye, Minghao et al.
DOI: 10.1681/ASN.2020050667

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

PMID: 33151035
Journal: EMBO Molecular Medicine
Year: 2020
Reference: EMBO Mol Med. 2020 Dec 7;12(12):e11889. doi: 10.15252/emmm.201911889. Epub 2020 Nov 5.
Impact factor: 8.821
Publication type: Paper in international publication
Authors: Moserle, Lidia, Pons, Roser, Martinez-Lozano, Mar, Jimenez-Valerio, Gabriela A, Vidal, August, Suarez, Cristina, Trilla, Enrique, Jimenez, Jose, de Torres, Ines, Carles, Joan et al.
DOI: 10.15252/emmm.201911889

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

PMID: 33151035
Journal: EMBO Molecular Medicine
Year: 2020
Reference: EMBO Mol Med. 2020 Dec 7;12(12):e11889. doi: 10.15252/emmm.201911889. Epub 2020 Nov 5.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar, Susana; Amadori, Alberto; Carles, Joan; Casanovas, Oriol; de Torres, Ines; Jimenez, Jose; Jimenez-Valerio, Gabriela A; Martinez-Lozano, Mar; Moserle, Lidia; Palomero, Luis et al.
DOI: 10.15252/emmm.201911889

Publications

Publications searcher

Isolated cerebral mucormycosis associated with intravenous drug use.

Isolated cerebral mucormycosis associated with intravenous drug use.

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

Italian consensus on treatment of spasticity in multiple sclerosis.

Italian consensus on treatment of spasticity in multiple sclerosis.

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

Patronage:

Collaborating:

Accreditations: